News | March 17, 2022
Biological E gears up for new phase of vaccination drive
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
This pre-packaged release is a ready-to-go solution with powerful, straightforward bioanalysis pipeline support
The USFDA has granted a qualified infectious disease product (QIDP) designation to WCK 6777, which signifies its ability to meet unmet medical needs and facilitates a faster approval process
Machine learning approach to systems biology combined with ligand discovery platform
Tapestri Platform powers Nature Cardiovascular Research publication that identifies two somatic mutations associated with sporadic brain blood vessel disorder
It is only the second generic application approved by the USFDA
Govt announces vaccination programme for kids and those above 60 years of age
Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
The money will be donated to the United Nations Children’s Fund (UNICEF)
Subscribe To Our Newsletter & Stay Updated
